Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Sanders-van Wijk

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Digital Health|September 29, 2025
Addressing pilotitis: A qualitative study on the implementation of eCoaches in hospital-based chronic careTanja E L M Schiffelers, Laura M J Hochstenbach, Esther Talboom-Kamp, et al.
Heart (British Cardiac Society)|January 13, 2026
Fluid restriction in patients with heart failure: a systematic reviewJob J Herrmann, Rachna van Berlo, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|May 4, 2018
Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial ResultsEdimar Alcides Bocchi, FÁtima das Dores da Cruz, Sara Michelly BrandÃo, et al.
Clinical Chemistry|March 4, 2016
Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HFSandra Sanders-van Wijk, Serge Masson, Valentina Milani, et al.
The International Journal of Cardiovascular Imaging|February 17, 2023
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular functionChristian Knackstedt, Georg Schummers, Jörg Schröder, et al.
Journal of Cardiac Failure|January 11, 2015
Differential prognostic impact of resting heart rate in older compared with younger patients with chronic heart failure--insights from TIME-CHFMarzena Zurek, Micha T Maeder, Hans Rickli, et al.
Circulation. Heart Failure|December 20, 2013
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHFSandra Sanders-van Wijk, Micha T Maeder, Fabian Nietlispach, et al.
European Journal of Heart Failure|September 1, 2019
Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fractionArantxa Barandiarán Aizpurua, Sandra Sanders-van Wijk, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|February 25, 2017
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHFNasser Davarzani, Sandra Sanders-van Wijk, Joël Karel, et al.
European Journal of Heart Failure|February 6, 2020
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trialRobert Stöhr, Vincent M Brandenburg, Gunnar H Heine, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Digital Health|September 29, 2025
Addressing pilotitis: A qualitative study on the implementation of eCoaches in hospital-based chronic careTanja E L M Schiffelers, Laura M J Hochstenbach, Esther Talboom-Kamp, et al.
Heart (British Cardiac Society)|January 13, 2026
Fluid restriction in patients with heart failure: a systematic reviewJob J Herrmann, Rachna van Berlo, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|May 4, 2018
Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial ResultsEdimar Alcides Bocchi, FÁtima das Dores da Cruz, Sara Michelly BrandÃo, et al.
Clinical Chemistry|March 4, 2016
Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HFSandra Sanders-van Wijk, Serge Masson, Valentina Milani, et al.
The International Journal of Cardiovascular Imaging|February 17, 2023
A graphical analysis of aspects contributing to the spreading of measurements of left ventricular functionChristian Knackstedt, Georg Schummers, Jörg Schröder, et al.
Journal of Cardiac Failure|January 11, 2015
Differential prognostic impact of resting heart rate in older compared with younger patients with chronic heart failure--insights from TIME-CHFMarzena Zurek, Micha T Maeder, Hans Rickli, et al.
Circulation. Heart Failure|December 20, 2013
Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHFSandra Sanders-van Wijk, Micha T Maeder, Fabian Nietlispach, et al.
European Journal of Heart Failure|September 1, 2019
Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fractionArantxa Barandiarán Aizpurua, Sandra Sanders-van Wijk, Hans-Peter Brunner-La Rocca, et al.
Journal of Cardiac Failure|February 25, 2017
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHFNasser Davarzani, Sandra Sanders-van Wijk, Joël Karel, et al.
European Journal of Heart Failure|February 6, 2020
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trialRobert Stöhr, Vincent M Brandenburg, Gunnar H Heine, et al.
Pageof 6